Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease
Top Cited Papers
Open Access
- 24 July 2014
- journal article
- practice guideline
- Published by American Society of Hematology in Blood
- Vol. 124 (4), 483-492
- https://doi.org/10.1182/blood-2014-03-561381
Abstract
Erdheim-Chester disease (ECD) is a rare, non-Langerhans histiocytosis. Recent findings suggest that ECD is a clonal disorder, marked by recurrent BRAKeywords
This publication has 98 references indexed in Scilit:
- Erdheim-Chester Disease: a comprehensive review of the literatureOrphanet Journal of Rare Diseases, 2013
- 18F-Fluoride PET/CT Aspect of an Unusual Case of Erdheim-Chester Disease With Histologic Features of Langerhans Cell HistiocytosisClinical Nuclear Medicine, 2013
- Erdheim–Chester disease with cardiac involvement successfully treated with anakinraInternational Journal of Cardiology, 2013
- Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-NetOrphanet Journal of Rare Diseases, 2013
- Progression of RAS-Mutant Leukemia during RAF Inhibitor TreatmentNew England Journal of Medicine, 2012
- B-RAF Mutant Alleles Associated with Langerhans Cell Histiocytosis, a Granulomatous Pediatric DiseasePLOS ONE, 2012
- Pulmonary langerhans cell histiocytosisOrphanet Journal of Rare Diseases, 2012
- Unusual manifestation of Erdheim-Chester diseaseBMC Gastroenterology, 2011
- Recurrent BRAF mutations in Langerhans cell histiocytosisBlood, 2010
- Improvement of Erdheim?Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetilClinical Rheumatology, 2004